The growth of a xenograft breast cancer tumor model with engineered hyaluronan-accumulating stroma is dependent on hyaluronan and independent of CD44
Authors:
Open Access
- 12 November 2019
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 10 (61) , 6561-6576
Abstract
Oncotarget | https://doi.org/10.18632/oncotarget.27302 Chunmei Zhao, Benjamin J. Thompson, Kelly Chen, Feng Gao, Barbara Blouw, Mathieu Marella, Susan Zimmerman, Trevor Kimbler, Sheryl Garrovillo, Jesse Bahn, Lei...Keywords
This publication has 57 references indexed in Scilit:
- Activated hyaluronan metabolism in the tumor matrix — Causes and consequencesMatrix Biology, 2019
- Targeting hyaluronan for the treatment of pancreatic ductal adenocarcinomaActa Pharmaceutica Sinica B, 2016
- Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti–PD-L1 immunotherapy in pancreatic cancerProceedings of the National Academy of Sciences of the United States of America, 2013
- Causes, consequences, and remedies for growth-induced solid stress in murine and human tumorsProceedings of the National Academy of Sciences, 2012
- Hydration Dynamics of Hyaluronan and DextranBiophysical Journal, 2012
- HYAL1 Hyaluronidase in Prostate Cancer: A Tumor Promoter and SuppressorCancer Research, 2005
- Elevated Hyaluronan Production Induces Mesenchymal and Transformed Properties in Epithelial CellsJournal of Biological Chemistry, 2003
- Absence of the CD44 gene prevents sarcoma metastasis.2002
- Pancreatic carcinoma is characterized by elevated content of hyaluronan and chondroitin sulfate with altered disaccharide compositionBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2000
- Tumor cell-associated hyaluronan as an unfavorable prognostic factor in colorectal cancer.1998